F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7

Cell Death and Disease

Volumn 6, Issue , 2015, Pages

  Liu, Y ^a   Lear, T ^a   Zhao, Y ^a   Zhao, J ^a   Zou, C ^a   Chen, B B ^a   Mallampalli, R K ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

F BOX AND LEUCINE RICH REPEAT PROTEIN 17; F BOX AND LEUCINE RICH REPEAT PROTEIN 18; F BOX PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; FBL6 PROTEIN, HUMAN; FBXL19 PROTEIN, HUMAN; LYSINE; POLYUBIQUITIN; PROTEASOME; PROTEIN SUBUNIT;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELL CYCLE PROGRESSION; CONJUGATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; NONHUMAN; POLYUBIQUITYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; ANIMAL; CELL LINE; CHEMISTRY; METABOLISM; MOUSE; PROTEIN MOTIF; PROTEIN SUBUNIT; PROTEIN TERTIARY STRUCTURE;

AMINO ACID MOTIFS; ANIMALS; APOPTOSIS; BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; F-BOX PROTEINS; HUMANS; LYSINE; MICE; POLYUBIQUITIN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; PROTEOLYSIS; UBIQUITINATION;

EID: 84923171541     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.585     Document Type: Article

References (29)

1. Tanaka Y, Tanaka N, Saeki Y, Tanaka K, Murakami M, Hirano T et al. c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130. Mol Cell Biol 2008; 28: 4805-4818.
2. Hershko A, Ciechanover A, Varshavsky A. Basic Medical Research Award. The ubiquitin system. Nat Med 2000; 6: 1073-1081.
3. Hochstrasser M. Biochemistry. All in the ubiquitin family. Science 2000; 289: 563-564.
4. Tyers M, Willems AR. One ring to rule a superfamily of E3 ubiquitin ligases. Science 1999; 284: 603-604.
5. Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases. Annu Rev Biochem 2009; 78: 399-434.
6. Cardozo T, Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol 2004; 5: 739-751.
7. Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P et al. Structure of the Cul1- Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002; 416: 703-709.
8. Skowyra D, Craig KL, Tyers M, Elledge SJ, Harper W. F-box proteins function as receptors to recruit phosphorylated substrates to E3 ubiquitin ligase complexes. Mol Biol Cell 1997; 8: 2059-2059.
9. Wang Z, Liu P, Inuzuka H, Wei W. Roles of F-box proteins in cancer. Nat Rev Cancer 2014; 14: 233-247.
10. Weathington NM, Mallampalli RK. Emerging therapies targeting the ubiquitin proteasome system in cancer. J Clin Invest 2014; 124: 6-12.
11. Lipkowitz S, Weissman AM. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer 2011; 11: 629-643.
12. Chen BB, Coon TA, Glasser JR, McVerry BJ, Zhao J, Zhao Y et al. A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nat Immunol 2013; 14: 470-479.
13. Cenciarelli C, Chiaur DS, Guardavaccaro D, Parks W, Vidal M, Pagano M. Identification of a family of human F-box proteins. Curr Biol 1999; 9: 1177-1179.
14. Ilyin GP, Rialland M, Glaise D, Guguen-Guillouzo C. Identification of a novel Skp2-like mammalian protein containing F-box and leucine-rich repeats. FEBS Lett 1999; 459: 75-79.
15. Yen HC, Xu Q, Chou DM, Zhao Z, Elledge SJ. Global protein stability profiling in mammalian cells. Science 2008; 322: 918-923.
16. Skaar JR, Pagan JK, Pagano M. Mechanisms and function of substrate recruitment by F-box proteins. Nat Rev Mol Cell Biol 2013; 14: 369-381.
17. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. Control of the SCF(Skp2- Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 2004; 428: 190-193.
18. Galan JM, Peter M. Ubiquitin-dependent degradation of multiple F-box proteins by an autocatalytic mechanism. Proc Natl Acad Sci USA 1999; 96: 9124-9129.
19. Coon TA, Glasser JR, Mallampalli RK, Chen BB. Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest. Cell Cycle 2012; 11: 721-729.
20. Kim S, Kon M, DeLisi C. Pathway-based classification of cancer subtypes. Biol Direct 2012; 7: 21.
21. Park HW, Dahlin A, Tse S, Duan QL, Schuemann B, Martinez FD et al. Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids. J Allergy Clin Immunol 2014; 133: 664-669 e665.
22. Tan MK, Lim HJ, Bennett EJ, Shi Y, Harper JW. Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover. Mol Cell 2013; 52: 9-24.
23. Zhao J, Wei J, Mialki RK, Mallampalli DF, Chen BB, Coon T et al. F-box protein FBXL19- mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation. Nat Immunol 2012; 13: 651-658.
24. Busino L, Millman SE, Scotto L, Kyratsous CA, Basrur V, O'Connor O et al. Fbxw7alpha- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma. Nat Cell Biol 2012; 14: 375-385.
25. Zou C, Chen Y, Smith RM, Snavely C, Li J, Coon TA et al. SCF(Fbxw15) mediates histone acetyltransferase binding to origin recognition complex (HBO1) ubiquitin-proteasomal degradation to regulate cell proliferation. J Biol Chem 2013; 288: 6306-6316.
26. Ganoth D. The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27. (vol 3, pg 321, 2001). Nat Cell Biol 2001; 3: 438-438.
27. Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW et al. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell 2001; 7: 639-650.
28. Chen BB, Coon TA, Glasser JR, Mallampalli RK. Calmodulin antagonizes a calciumactivated SCF ubiquitin E3 ligase subunit, FBXL2, to regulate surfactant homeostasis. Mol Cell Biol 2011; 31: 1905-1920.
29. Kishi T, Yamao F. An essential function of Grr1 for the degradation of Cln2 is to act as a binding core that links Cln2 to Skp1. J Cell Sci 1998; 111: 3655-3661.